{
  "id": "517194ef8ed59a060a000011",
  "type": "factoid",
  "question": "Which is the causative agent of malaria?",
  "ideal_answer": "Four Plasmodium species commonly infect humans (Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale). Plasmodium falciparum infects about 5-10% of the world human population per year and it is the causative agent of the most severe and lethal form of malaria. P. falciparum  causes fatal cerebral malaria and is responsible for most deaths, particularly in pregnant women and children under the age of five. P. falciparum is transmitted to the human host by Anopheles mosquitoes and is the most tremendous malaria vector in sub-Saharan Africa. Plasmodium vivax is the causative agent of benign malaria in more temperate climates of the world. Plasmodium gallinaceum is the main bird malaria causative agent and  Plasmodium yoelli is the principle rodent malaria agent.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/12930149",
    "http://www.ncbi.nlm.nih.gov/pubmed/15003844",
    "http://www.ncbi.nlm.nih.gov/pubmed/15117937",
    "http://www.ncbi.nlm.nih.gov/pubmed/19184366",
    "http://www.ncbi.nlm.nih.gov/pubmed/20635416",
    "http://www.ncbi.nlm.nih.gov/pubmed/14556002",
    "http://www.ncbi.nlm.nih.gov/pubmed/19779742",
    "http://www.ncbi.nlm.nih.gov/pubmed/19666023",
    "http://www.ncbi.nlm.nih.gov/pubmed/21670272",
    "http://www.ncbi.nlm.nih.gov/pubmed/22819049",
    "http://www.ncbi.nlm.nih.gov/pubmed/11504465",
    "http://www.ncbi.nlm.nih.gov/pubmed/14638789",
    "http://www.ncbi.nlm.nih.gov/pubmed/22341220",
    "http://www.ncbi.nlm.nih.gov/pubmed/21206476",
    "http://www.ncbi.nlm.nih.gov/pubmed/12626578",
    "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
    "http://www.ncbi.nlm.nih.gov/pubmed/23405174",
    "http://www.ncbi.nlm.nih.gov/pubmed/20078859",
    "http://www.ncbi.nlm.nih.gov/pubmed/15701514",
    "http://www.ncbi.nlm.nih.gov/pubmed/21297002",
    "http://www.ncbi.nlm.nih.gov/pubmed/10585859",
    "http://www.ncbi.nlm.nih.gov/pubmed/23246819",
    "http://www.ncbi.nlm.nih.gov/pubmed/22524128",
    "http://www.ncbi.nlm.nih.gov/pubmed/18522993",
    "http://www.ncbi.nlm.nih.gov/pubmed/18925948",
    "http://www.ncbi.nlm.nih.gov/pubmed/15293910",
    "http://www.ncbi.nlm.nih.gov/pubmed/12929205",
    "http://www.ncbi.nlm.nih.gov/pubmed/12139027",
    "http://www.ncbi.nlm.nih.gov/pubmed/20034997",
    "http://www.ncbi.nlm.nih.gov/pubmed/22216006",
    "http://www.ncbi.nlm.nih.gov/pubmed/21866942",
    "http://www.ncbi.nlm.nih.gov/pubmed/16203971",
    "http://www.ncbi.nlm.nih.gov/pubmed/18248630",
    "http://www.ncbi.nlm.nih.gov/pubmed/20702404",
    "http://www.ncbi.nlm.nih.gov/pubmed/1813841",
    "http://www.ncbi.nlm.nih.gov/pubmed/15339111",
    "http://www.ncbi.nlm.nih.gov/pubmed/18989463",
    "http://www.ncbi.nlm.nih.gov/pubmed/22543099",
    "http://www.ncbi.nlm.nih.gov/pubmed/19038338",
    "http://www.ncbi.nlm.nih.gov/pubmed/22222968",
    "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
    "http://www.ncbi.nlm.nih.gov/pubmed/17822713",
    "http://www.ncbi.nlm.nih.gov/pubmed/15033330",
    "http://www.ncbi.nlm.nih.gov/pubmed/22990975",
    "http://www.ncbi.nlm.nih.gov/pubmed/19931645",
    "http://www.ncbi.nlm.nih.gov/pubmed/21698217",
    "http://www.ncbi.nlm.nih.gov/pubmed/23326533",
    "http://www.ncbi.nlm.nih.gov/pubmed/22563351",
    "http://www.ncbi.nlm.nih.gov/pubmed/22628552",
    "http://www.ncbi.nlm.nih.gov/pubmed/22929299",
    "http://www.ncbi.nlm.nih.gov/pubmed/3911876",
    "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
    "http://www.ncbi.nlm.nih.gov/pubmed/20500669",
    "http://www.ncbi.nlm.nih.gov/pubmed/12125103",
    "http://www.ncbi.nlm.nih.gov/pubmed/14627712",
    "http://www.ncbi.nlm.nih.gov/pubmed/14514358",
    "http://www.ncbi.nlm.nih.gov/pubmed/15878595",
    "http://www.ncbi.nlm.nih.gov/pubmed/19706885",
    "http://www.ncbi.nlm.nih.gov/pubmed/19013823",
    "http://www.ncbi.nlm.nih.gov/pubmed/10703207",
    "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
    "http://www.ncbi.nlm.nih.gov/pubmed/10744765",
    "http://www.ncbi.nlm.nih.gov/pubmed/11087748",
    "http://www.ncbi.nlm.nih.gov/pubmed/22507744",
    "http://www.ncbi.nlm.nih.gov/pubmed/15265796",
    "http://www.ncbi.nlm.nih.gov/pubmed/23046708",
    "http://www.ncbi.nlm.nih.gov/pubmed/15463447",
    "http://www.ncbi.nlm.nih.gov/pubmed/18611947",
    "http://www.ncbi.nlm.nih.gov/pubmed/17868038",
    "http://www.ncbi.nlm.nih.gov/pubmed/15147974",
    "http://www.ncbi.nlm.nih.gov/pubmed/22359643",
    "http://www.ncbi.nlm.nih.gov/pubmed/11115107",
    "http://www.ncbi.nlm.nih.gov/pubmed/18672695",
    "http://www.ncbi.nlm.nih.gov/pubmed/16458301",
    "http://www.ncbi.nlm.nih.gov/pubmed/18221799",
    "http://www.ncbi.nlm.nih.gov/pubmed/18295508",
    "http://www.ncbi.nlm.nih.gov/pubmed/11687659",
    "http://www.ncbi.nlm.nih.gov/pubmed/3011062",
    "http://www.ncbi.nlm.nih.gov/pubmed/2067482",
    "http://www.ncbi.nlm.nih.gov/pubmed/14609342",
    "http://www.ncbi.nlm.nih.gov/pubmed/19768685",
    "http://www.ncbi.nlm.nih.gov/pubmed/21570407",
    "http://www.ncbi.nlm.nih.gov/pubmed/9874251",
    "http://www.ncbi.nlm.nih.gov/pubmed/21601941",
    "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
    "http://www.ncbi.nlm.nih.gov/pubmed/23293353",
    "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
    "http://www.ncbi.nlm.nih.gov/pubmed/11796125",
    "http://www.ncbi.nlm.nih.gov/pubmed/4047719",
    "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
    "http://www.ncbi.nlm.nih.gov/pubmed/15073329",
    "http://www.ncbi.nlm.nih.gov/pubmed/11839179",
    "http://www.ncbi.nlm.nih.gov/pubmed/18082626",
    "http://www.ncbi.nlm.nih.gov/pubmed/23484017",
    "http://www.ncbi.nlm.nih.gov/pubmed/21989409",
    "http://www.ncbi.nlm.nih.gov/pubmed/21904052",
    "http://www.ncbi.nlm.nih.gov/pubmed/15950069",
    "http://www.ncbi.nlm.nih.gov/pubmed/20610151",
    "http://www.ncbi.nlm.nih.gov/pubmed/18628947",
    "http://www.ncbi.nlm.nih.gov/pubmed/9514077",
    "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
    "http://www.ncbi.nlm.nih.gov/pubmed/22057268",
    "http://www.ncbi.nlm.nih.gov/pubmed/19801158",
    "http://www.ncbi.nlm.nih.gov/pubmed/11559352",
    "http://www.ncbi.nlm.nih.gov/pubmed/19706490",
    "http://www.ncbi.nlm.nih.gov/pubmed/8300589",
    "http://www.ncbi.nlm.nih.gov/pubmed/18164079",
    "http://www.ncbi.nlm.nih.gov/pubmed/19380379",
    "http://www.ncbi.nlm.nih.gov/pubmed/11085920",
    "http://www.ncbi.nlm.nih.gov/pubmed/15703443",
    "http://www.ncbi.nlm.nih.gov/pubmed/7715553",
    "http://www.ncbi.nlm.nih.gov/pubmed/20353400",
    "http://www.ncbi.nlm.nih.gov/pubmed/8631352",
    "http://www.ncbi.nlm.nih.gov/pubmed/16222020",
    "http://www.ncbi.nlm.nih.gov/pubmed/18563912",
    "http://www.ncbi.nlm.nih.gov/pubmed/21329764",
    "http://www.ncbi.nlm.nih.gov/pubmed/16042788",
    "http://www.ncbi.nlm.nih.gov/pubmed/22592550",
    "http://www.ncbi.nlm.nih.gov/pubmed/21771420",
    "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
    "http://www.ncbi.nlm.nih.gov/pubmed/23483940",
    "http://www.ncbi.nlm.nih.gov/pubmed/23349974",
    "http://www.ncbi.nlm.nih.gov/pubmed/19267910",
    "http://www.ncbi.nlm.nih.gov/pubmed/22019287",
    "http://www.ncbi.nlm.nih.gov/pubmed/17024857",
    "http://www.ncbi.nlm.nih.gov/pubmed/23342028",
    "http://www.ncbi.nlm.nih.gov/pubmed/22028927",
    "http://www.ncbi.nlm.nih.gov/pubmed/9927744",
    "http://www.ncbi.nlm.nih.gov/pubmed/19020475",
    "http://www.ncbi.nlm.nih.gov/pubmed/15246528",
    "http://www.ncbi.nlm.nih.gov/pubmed/6760901",
    "http://www.ncbi.nlm.nih.gov/pubmed/21209090",
    "http://www.ncbi.nlm.nih.gov/pubmed/1474844"
  ],
  "snippets": [
    {
      "text": "lasmodium falciparum the main causative agent of malaria is an important public health vector.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum the main causative agent of malaria is an important public health vector. <",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Overcoming antigenic variation is one of the major challenges in the development of an effective vaccine against Plasmodium falciparum, a causative agent of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23293353",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "[The vivax malaria causative agent Plasmodium ovale: the present global area, intraspecies polymorphism, importation to the Russian Federation (1992-2011)].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The global area for Plasmodium ovale is small as compared with that for other species of human malaria pathogens.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Parasites that have been described to affect the central nervous system (CNS), either as the dominant or as a collateral feature, include cestodes (Taenia solium (neurocysticerciasis), Echinococcus granulosus (cerebral cystic echinococcosis), E. multilocularis (cerebral alveolar echinococcosis), Spirometra mansoni (neurosparganosis)), nematodes (Toxocara canis and T. cati (neurotoxocariasis), Trichinella spiralis (neurotrichinelliasis), Angiostrongylus cantonensis and A. costaricensis (neuroangiostrongyliasis), Gnathostoma spinigerum (gnathostomiasis)), trematodes (Schistosoma mansoni (cerebral bilharziosis), Paragonimus westermani (neuroparagonimiasis)), or protozoa (Toxoplasma gondii (neurotoxoplasmosis), Acanthamoeba spp. or Balamuthia mandrillaris (granulomatous amoebic encephalitis), Naegleria (primary amoebic meningo-encephalitis), Entamoeba histolytica (brain abscess), Plasmodium falciparum (cerebral malaria), Trypanosoma brucei gambiense/rhodesiense (sleeping sickness) or Trypanosoma cruzi (cerebral Chagas disease))",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23046708",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of malaria, a deadly infectious disease for which treatments are scarce and drug-resistant parasites are now increasingly found.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819049",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In contrast, it has been thought that Plasmodium spp., the causative agent of malaria, rely mainly on cytosolic glycolysis but not mitochondrial oxidative phosphorylation for energy production during blood stages.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22628552",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Whereas no biological activity was previously identified for 1, the material derived from the efficient synthesis enabled additional bioactivity tests leading to the identification of a notable activity against insect cells and Plasmodium falciparum, the causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563351",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malaria, encodes an SSB protein that localizes to the apicoplast and likely functions in the replication and maintenance of its genome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22543099",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "While observing cells by time-lapse imaging is a standard procedure in many systems, this technique was until recently not available for blood stages of Plasmodium falciparum, the causative agent of the most severe form of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22341220",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The causative agent of malaria, Plasmodium, possesses three translationally active compartments: the cytosol, the mitochondrion and a relic plastid called the apicoplast.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22222968",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The merozoite surface protein (MSP)-1 of Plasmodium falciparum, the causative agent of malaria tropica, is considered to be a promising vaccine candidate.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The genus Plasmodium, the causative agent of malaria, has the smallest mt genome in the form of a tandemly repeated, linear element of 6 kb.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21329764",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The culminating step of the intraerythrocytic development of Plasmodium falciparum, the causative agent of malaria, is the spectacular release of multiple invasive merozoites on rupture of the infected erythrocyte membrane.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21297002",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of human malaria, lacks a conventional tricarboxylic acid cycle and depends exclusively on glycolysis for ATP production.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21209090",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most deadly form of human malaria, is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20702404",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The Hsp90 protein from the parasite Plasmodium falciparum, the causative agent of malaria, is critical for this organism's survival; the anti-Hsp90 drug geldanamycin is toxic to P. falciparum growth.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20635416",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A novel family of 1H-imidazol-2-yl-pyrimidine-4,6-diamines has been identified with potent activity against the erythrocyte-stage of Plasmodium falciparum (Pf), the most common causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20610151",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The Plasmodium parasite, causative agent of malaria, infects RBC that are phagocytosed by DC and macrophages during the course of infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20500669",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of malaria, a disease where new drug targets are required due to increasing resistance to current anti-malarials.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20353400",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of human malaria, invades host erythrocytes using several proteins on the surface of the invasive merozoite, which have been proposed as potential vaccine candidates.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931645",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Few studies have investigated the pathophysiologic mechanisms responsible for what seems to be a possible interaction between Plasmodium falciparum, the causative agent of malaria, and HIV-1 in dually infected patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19801158",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We show that orthochromatic cells are the earliest stages that may be invaded by Plasmodium falciparum, the causative agent of fatal human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706885",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Infection by Plasmodium, the causative agent of malaria, is associated with hemolysis and therefore with release of hemoglobin from RBC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706490",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malignant malaria, is among the most severe human infectious diseases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the most important causative agent of human malaria, undergoes antigenic variation as a means of prolonging infection and ensuring transmission between hosts.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666023",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "L-Malate dehydrogenase (PfMDH) from Plasmodium falciparum, the causative agent for the most severe form of malaria, has shown remarkable similarities to L: -lactate dehydrogenase (PfLDH).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19184366",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "FQ is able to overcome the chloroquine (CQ) resistance problem, an important limit to the control of Plasmodium falciparum, the principal causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18563912",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The causative agent of malaria, Plasmodium falciparum posses a single aquaglyceroporin (PfAQP) which represents a potential drug target for treatment of the disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18295508",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "An essential requisite for transmission of Plasmodium, the causative agent of malaria, is the successful completion of a complex developmental cycle in its mosquito vector.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18248630",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In Plasmodium falciparum, the causative agent of cerebral malaria, silent information regulator 2 (Sir2) has been implicated in pathogenesis through its role in var gene silencing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18221799",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of human malaria, is totally dependent on de novo pyrimidine biosynthetic pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18082626",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the fatal form of malaria, synthesizes GMP primarily from IMP and, hence, needs active GMPS (GMP synthetase) for its survival.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17868038",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of the most severe type of malaria, a life-threatening disease affecting the lives of over three billion people.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17822713",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most serious form of malaria, infects about 5-10% of the world human population per year.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17024857",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium vivax is an important human pathogen causing malaria in more temperate climates of the world. Similar to Plasmodium falciparum, the causative agent for malaria tropica, drug resistance is beginning to emerge for this parasite species and this hampers adequate treatment of infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16458301",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Malaria kills more than one million people a year, and understanding the historical association between its most notorious causative agent, Plasmodium falciparum, and its mosquito vectors is important in fighting the disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16222020",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We show here that macrophages are mandatory for NK cell IFN-gamma secretion in response to erythrocytes infected with Plasmodium falciparum (Pf), a causative agent of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16203971",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of the most severe and mortal type of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15950069",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the main causative agent of tropical malaria, the most severe parasitic disease in the world. Growing resistance of Plasmodia towards available drugs is an increasing problem in countries where malaria is endemic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15878595",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The presence of antisense RNA in Plasmodium falciparum, the causative agent of severe malaria, remains controversial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15703443",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malaria, is sensitive to oxidative stress and therefore the family of antioxidant enzymes, peroxiredoxins (Prxs) represent a target for antimalarial drug design.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15701514",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In the Republic of Yemen, Plasmodium falciparum is the predominant causative agent of malaria and is associated with adverse consequences for pregnant women and their babies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15339111",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, uses multiple ligand-receptor interactions to invade host red blood cells (RBCs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15265796",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Comparative genomic analysis of the malaria causative agent, Plasmodium falciparum, with other eukaryotes for which the complete genome is available, revealed that the genome from P. falciparum was more similar to the genome of a plant, Arabidopsis thaliana, than to other non-apicomplexan taxa.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246528",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, totally depends on de novo pyrimidine biosynthetic pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15147974",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malaria, relies extensively on glycolysis coupled with homolactic fermentation during its blood-borne stages for energy production.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15117937",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of the most severe form of human malaria. The rapid multiplication of the parasite within human erythrocytes requires an active production of new membranes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15073329",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Seven sPLA(2)s from groups IA, IB, IIA and III, were tested here in different culture conditions for inhibition of the in vitro intraerythrocytic development of Plasmodium falciparum, the causative agent of the most severe form of human malaria",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15033330",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, relies on de novo pyrimidine biosynthesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15003844",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14638789",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium, the causative agent of malaria, has to undergo sexual differentiation and development in anopheline mosquitoes for transmission to occur.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14627712",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "For Plasmodium falciparum, a causative agent of tropical malaria, TrxR is an essential protein which has been validated as a drug target.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14609342",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium, the causative agent of malaria, must first infect hepatocytes to initiate a mammalian infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14556002",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Cyclin dependent protein kinases (CDKs) have become attractive drug targets in an effort to identify effective inhibitors of the parasite Plasmodium falciparum, the causative agent of the most severe form of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12930149",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "It is well established that protection against one such disease, malaria, requires strong CD8(+) T cell responses targeted against the liver stages of the causative agent, Plasmodium spp.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12626578",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A novel method for the in vitro detection of the protozoan Plasmodium, the causative agent of malaria, has been developed.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12139027",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Trypanosomes do not inhabit or grow in anopheles mosquitoes, the vector for the transmission of Plasmodium parasites the causative agent for malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12125103",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The genome sequence of Plasmodium falciparum, the causative agent of the most severe form of malaria in humans, rapidly approaches completion, but our ability to genetically manipulate this organism remains limited.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11796125",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "It is caused by a number of species of the genus Plasmodium, and Plasmodium falciparum is the causative agent of the most lethal form.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11839179",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "To complete its life cycle in the mosquito, Plasmodium, the causative agent of malaria, has to traverse the epithelia of the midgut and salivary glands.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11687659",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In Plasmodium falciparum, the causative agent of human malaria, the catalytic subunit gene of cAMP-dependent protein kinase (Pfpka-c) exists as a single copy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11559352",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Sulfadoxine is the most extensively used drug of this group of drugs and is usually combined with pyrimethamine (Fansidar), particularly for the control of Plasmodium falciparum, the causative agent of the most lethal form of malaria. Resistance to the sulfadoxine/pyrimethamine combination is widespread.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11504465",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A putative glutathione peroxidase gene (Swiss-Prot accession number Z 68200) of Plasmodium falciparum, the causative agent of tropical malaria, was expressed in Escherichia coli and purified to electrophoretic homogeneity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11087748",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Apical membrane antigen 1 (AMA1) is an asexual blood-stage protein expressed in the invasive merozoite form of Plasmodia species, which are the causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11115107",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In the case of Plasmodium falciparum, the causative agent of malaria tropica, this approach is especially interesting, because here both key enzymes, ODC and AdoMetDC, are combined in a bifunctional protein, ODC/AdoMetDC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085920",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, is incapable of de novo purine synthesis, and thus, purine acquisition from the host is an indispensable nutritional requirement.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10744765",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A laboratory model of circulation of the malaria causative agent P. gallinaceum has been used to show that the effect of precocene (antijuvenoid) leads to a statistically significant reduction in the proportion of infected females developing eggs after blood suction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10703207",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A cell-free incubation system prepared from asexual erythrocytic stages of Plasmodium falciparum, the causative agent of malaria in humans, is capable of synthesizing the same spectrum of GPIs as that found in metabolically labelled parasites.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10585859",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The Plasmodium falciparum malaria parasite is the causative agent of malaria tropica.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9927744",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The gene of an NADP+-specific glutamate dehydrogenase was cloned from Plasmodium falciparum, the causative agent of tropical malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9874251",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "This study describes the synergistic interaction of two calcium channel blockers, verapamil (VR) and SR33557 or fantofarone (SR), in reversing chloroquine resistance in Plasmodium falciparum, the causative agent of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9514077",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the major causative agent of malaria, a disease of worldwide importance.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Two enzymes were purified to homogeneity from the intraerythrocytic malarial parasite Plasmodium falciparum: glutathione disulfide reductase, an antioxidative enzyme, which appears to play an essential role for parasite growth and differentiation, and glutamate dehydrogenase, an enzyme not occurring in the host erythrocyte.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8631352",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The paper provides evidence that the An. sacharovi females which do not develop mature eggs after blood-sucking on the malaria-infected donor could not be infected by the bird malaria agent P. gallinaceum.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7715553",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of malaria tropica in man.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8300589",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plastid origin of an extrachromosomal DNA molecule from Plasmodium, the causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1474844",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "[New models of the circulation of the causative agent of malaria Plasmodium gallinaceum using malarial mosquitoes in the fauna of the USSR].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1813841",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "[Experimental research on the effect of biologically active substances on the susceptibility of mosquitoes to the causative agent of malaria. 3. Algae, fertilizers].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "On a model pair Aedes aegypti--Plasmodium gallinaceum in has been shown that changes in the conditions of larvae development caused by the addition into the water medium of the live culture of Synochocystis sp. cyanobacteria or green seaweeds Chlorella vulgaris, acetone extracts from the live culture precipitate or Chlorella powder, as well as nitrogen-containing fertilizer--ammonium chloride did not lower the sensitivity of the imago flying to malaria parasites.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The mechanism of chloroquine resistance has not been known but recent evidence from Plasmodium falciparum, the causative agent of the most severe form of human malaria, suggested similarities to the multidrug resistance phenotype (MDR) of mammalian tumour cells which is mediated by a protein molecule termed P-glycoprotein.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15463447",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The feasibility was determined of influencing Ae. aegypti sensitivity to bird malaria agent P. gallinaceum by sublethal concentrations of herbicides (ordram and propanide) and fungicides (fundozol and blue vitriol) introduced into the larvae habitation medium or into the imago feed.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067482",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "[An experimental study of the effect of different biologically active substances on the susceptibility of mosquitoes to the causative agent of malaria. 1. Insect development regulators].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "It has been shown on the model pair Ae. aegypti-P. gallinaceum that dimilin, an inhibitor of insect chitin synthesis has practically no effect on female sensitivity to malaria agent.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "[The absence of an action of the pyrethroids deltamethrin and cypermethrin on mosquito susceptibility to the causative agent of malaria].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Mosquitos Ae. aegypti and An. stephensi contact with sublethal doses of deltametrin and cypermetrin pyretroids at larval stage and in grown state, when diet includes sugar with pyretroids, had no influence on the sensitivity of survived females to malaria agents P. gallinaceum and P. berghei.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "This prompted us to purify and characterize the topoisomerases I and II present in the erythrocytes of protozoan parasites of the genus Plasmodium, the causative agent of malaria, in order to later use these enzymatic systems in antimalarial drug assays.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3011062",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The problem of drug resistance of Plasmodium falciparum, the causative agent of tropical malaria and its role in the general system of malaria control are discussed.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/3911876",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "[Effect of mosquito contact with DDT and their susceptibility to the causative agent of malaria].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/4047719",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "[Lack of an effect from repeated blood sucking by mosquitoes on their infectivity with the causative agent of malaria].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The lack of repeated bloodsucking does not affect essentially the infection of Ae. aegypti mosquitoes with malaria agent, P. gallinaceum.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "High resolution 31P-NMR has been used for the non-invasive observation of metabolites and metabolic rates in blood of normal mice and of mice infected with Plasmodium berghei, the causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6760901",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "BACKGROUND: Plasmodium falciparum the main causative agent of malaria is an important public health vector.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The effectiveness of methylene blue (MB) combined with pyrimethamine (PYR), chloroquine (CQ) or quinine (Q) was examined in a classical four-day suppressive test against a causative agent of rodent malaria, Plasmodium berghei.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22990975",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Infection by Plasmodium species, the causative agent of malaria, is currently treated with drug-based therapies, but an increase in drug resistance has led to the need for new methods of treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22592550",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "BACKGROUND: The merozoite surface protein (MSP)-1 of Plasmodium falciparum, the causative agent of malaria tropica, is considered to be a promising vaccine candidate.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The 23-megabase genome of Plasmodium falciparum, the causative agent of severe human malaria, contains \u223c5300 genes, most of unknown function or lacking homologs in other organisms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22057268",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Results of the present study indicate that malaria is endemic in Nouakchott and that P. vivax is the principal causative agent.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22019287",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium vivax was the main causative agent followed by Plasmodium falciparum.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21771420",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Toxoplasma gondii is a member of the phylum Apicomplexa that includes several important human pathogens, such as Cryptosporidium and Plasmodium falciparum, the causative agent of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21670272",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the major causative agent of human malaria, contains three separate genomes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21570407",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium parasites, the causative agent of malaria, are transmitted through the bites of infected Anopheles mosquitoes resulting in over 250 million new infections each year.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21206476",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The genus Plasmodium, causative agent of malaria, of the phylum Apicomplexa, has the smallest mt genome in the form of a circular and/or tandemly repeated linear element of 6 kb, encoding only three protein genes (cox1, cox3, and cob).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20034997",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum is the causative agent of the most lethal form of human malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19779742",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "In Plasmodium falciparum, the causative agent of the most lethal form of malaria, fatty acid biosynthesis occurs in the apicoplast organelle during the liver stage of the parasite life cycle.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19768685",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malignant malaria, is among the most severe human infectious diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "For transmission to occur, Plasmodium, the causative agent of malaria, must complete a complex developmental cycle in its mosquito vector.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19038338",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "FQ is able to overcome the CQ resistance problem, an important limit to the control of Plasmodium falciparum, the principal causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19020475",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Some lycorine ester derivatives including LT1 were examined for their inhibitory activity against Trypanosoma brucei brucei, the parasite associated with sleeping sickness, and against Plasmodium falciparum, the causative agent of malaria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19013823",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A three-dimensional structure of histo-aspartic protease (HAP), a pepsin-like enzyme from the causative agent of malaria Plasmodium falciparum, is suggested on the basis of homologous modeling followed by equilibration by the method of molecular dynamics.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18672695",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "BACKGROUND: Understanding gene regulation in Plasmodium, the causative agent of malaria, is an important step in deciphering its complex life cycle as well as leading to possible new targets for therapeutic applications.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18611947",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Plasmodium falciparum, the causative agent of malaria, relies on a complex protein-secretion system for protein targeting into numerous subcellular destinations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18522993",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We have evaluated a technology called transcriptionally active PCR (TAP) for high throughput identification and prioritization of novel target antigens from genomic sequence data using the Plasmodium parasite, the causative agent of malaria, as a model.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18164079",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008288",
    "http://www.disease-ontology.org/api/metadata/DOID:12978",
    "http://www.disease-ontology.org/api/metadata/DOID:14067",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010965",
    "http://www.disease-ontology.org/api/metadata/DOID:12365",
    "http://www.disease-ontology.org/api/metadata/DOID:14324",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016778",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016780"
  ],
  "exact_answer": "Plasmodium species, Plasmodium spp."
}